Business


People On The Move: Appointments At ANEFP, Pharma Deutschland, Salus

 
• By 

A round up of the latest people moves in Europe: ANEFP names president; Pharma Deutschland makes board changes; Salus shakes up management.

Opella Keeps French Commitments with €40m Investment

 
• By 

Opella is honoring its commitment to maintaining production volumes, investment levels, and jobs at its French plants by spending €40m to upgrade two sites in the country.

PAGB Wants 25 Rx-To-OTC Switches Over Next Five Years In The UK

 
• By 

UK consumer healthcare industry association, PAGB, suggests improvements that could help accelerate Rx-to-OTC switch in the country.

US Makes First Reformulated Ranitidine Approval Since Withdrawal, Starting With Rx Tablets

 

In announcement of approving VKT Pharma’s application, FDA included storage and handling instructions common in labeling, suggesting concerns persist about the potential for NDMA to form after products are distributed.

Innovation & IP


OTC Marketing Awards 2025: What The Judges Said About The Leading Entries

 
• By 

The trophies have been presented at the OTC Marketing Awards 2025 - but what did the judging panel have to say about the winning and highly-commended entries?

Opella Takes Top Prize At OTC Marketing Awards 2025

 
• By 

Winners across 12 categories were announced at the OTC Marketing Awards 2025 on 20 November, with Opella crowned OTC Company of the Year.

Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls

 
• By 

Self-Care Week Special: HBW Insight catches up with PAGB CEO Michelle Riddalls OBE to talk about what the association is doing to promote Rx-to-OTC switch in the UK.

Bayer: Product Launches Alone ‘Not Enough’ To Meet Women’s Health Needs

 
• By 

“It’s not good enough just to provide products anymore, we need to create a service and a holistic approach to products,” argued Bayer Consumer Health's Northern Europe general manager, Mike Knowland, speaking at a recent panel event in the UK Parliament.

Policy & Regulation


EU Deforestation Law: Parliament Votes For Delay For All Manufacturers Until End Of 2026

 
• By 

While no doubt welcome, yet another delay to the EU Deforestation Law and suggestion for another review next year could mean a “never-ending” regulatory exercise that creates uncertainty for manufacturers selling products containing or having been made using materials like palm oil, soya and wood.

People On The Move: Appointments At ANEFP, Pharma Deutschland, Salus

 
• By 

A round up of the latest people moves in Europe: ANEFP names president; Pharma Deutschland makes board changes; Salus shakes up management.

PAGB Wants 25 Rx-To-OTC Switches Over Next Five Years In The UK

 
• By 

UK consumer healthcare industry association, PAGB, suggests improvements that could help accelerate Rx-to-OTC switch in the country.

‘Fake News’ And Chatbots Pose Threat To Italy’s Responsible Self-Medication Model

 
• By 

A new cohort of “techno-enthusiasts” who are highly susceptible to misinformation and inappropriate self-care decisions are undermining Italy's responsible self-medication model, finds a report by Italian self-care industry association, Assosalute, and independent researcher Censis.

Rx-to-OTC Switch


US OTC Switches: FDA Needs Comments To Guide Public Meeting, Congress Wants Progress Report

 

Agency intends to use information from comments to guide its planning for a public meeting during 2026, according to a Federal Register notice. A GAO report is due in a year to Congress profiling FDA’s progress on making more drugs available nonprescription through OTC switch applications.

PAGB Wants 25 Rx-To-OTC Switches Over Next Five Years In The UK

 
• By 

UK consumer healthcare industry association, PAGB, suggests improvements that could help accelerate Rx-to-OTC switch in the country.

‘Fake News’ And Chatbots Pose Threat To Italy’s Responsible Self-Medication Model

 
• By 

A new cohort of “techno-enthusiasts” who are highly susceptible to misinformation and inappropriate self-care decisions are undermining Italy's responsible self-medication model, finds a report by Italian self-care industry association, Assosalute, and independent researcher Censis.

Opella: Unlock Volume Growth By Expanding Access And Deepening Category Penetration

 
• By 

Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.